nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—NR0B1—Vincristine—sarcoma	0.167	0.221	CbGbCtD
Dexamethasone—NOS2—Doxorubicin—sarcoma	0.0872	0.116	CbGbCtD
Dexamethasone—CYP1B1—Mitoxantrone—sarcoma	0.0483	0.0641	CbGbCtD
Dexamethasone—CYP2B6—Thiotepa—sarcoma	0.0376	0.0498	CbGbCtD
Dexamethasone—ABCB11—Vincristine—sarcoma	0.0333	0.0441	CbGbCtD
Dexamethasone—CYP1A1—Dacarbazine—sarcoma	0.0273	0.0362	CbGbCtD
Dexamethasone—ABCG2—Dactinomycin—sarcoma	0.0257	0.034	CbGbCtD
Dexamethasone—ABCG2—Mitoxantrone—sarcoma	0.023	0.0305	CbGbCtD
Dexamethasone—CYP2E1—Dacarbazine—sarcoma	0.0211	0.028	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—sarcoma	0.0208	0.0276	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—sarcoma	0.0208	0.0276	CbGbCtD
Dexamethasone—ABCC2—Vincristine—sarcoma	0.0175	0.0232	CbGbCtD
Dexamethasone—CYP2E1—Mitoxantrone—sarcoma	0.0164	0.0217	CbGbCtD
Dexamethasone—ABCC2—Etoposide—sarcoma	0.016	0.0213	CbGbCtD
Dexamethasone—PTGS2—Etoposide—sarcoma	0.0158	0.021	CbGbCtD
Dexamethasone—ABCG2—Vincristine—sarcoma	0.0158	0.021	CbGbCtD
Dexamethasone—ABCG2—Etoposide—sarcoma	0.0145	0.0192	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0117	0.0155	CbGbCtD
Dexamethasone—CYP3A7—Vincristine—sarcoma	0.0117	0.0155	CbGbCtD
Dexamethasone—CYP3A4—Thiotepa—sarcoma	0.0115	0.0153	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—sarcoma	0.0109	0.0145	CbGbCtD
Dexamethasone—CYP2E1—Etoposide—sarcoma	0.0103	0.0137	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—sarcoma	0.00988	0.0131	CbGbCtD
Dexamethasone—ABCB1—Dactinomycin—sarcoma	0.00926	0.0123	CbGbCtD
Dexamethasone—CYP3A5—Vincristine—sarcoma	0.00876	0.0116	CbGbCtD
Dexamethasone—ABCB1—Mitoxantrone—sarcoma	0.00828	0.011	CbGbCtD
Dexamethasone—CYP3A5—Etoposide—sarcoma	0.00803	0.0106	CbGbCtD
Dexamethasone—CYP2C8—Etoposide—sarcoma	0.00772	0.0102	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—sarcoma	0.00695	0.00922	CbGbCtD
Dexamethasone—ABCB1—Vincristine—sarcoma	0.0057	0.00756	CbGbCtD
Dexamethasone—ABCB1—Etoposide—sarcoma	0.00522	0.00693	CbGbCtD
Dexamethasone—CYP3A4—Mitoxantrone—sarcoma	0.00496	0.00658	CbGbCtD
Dexamethasone—ABCB1—Doxorubicin—sarcoma	0.00356	0.00472	CbGbCtD
Dexamethasone—CYP3A4—Vincristine—sarcoma	0.00342	0.00453	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—sarcoma	0.00336	0.00445	CbGbCtD
Dexamethasone—CYP3A4—Etoposide—sarcoma	0.00313	0.00415	CbGbCtD
Dexamethasone—CYP3A4—Doxorubicin—sarcoma	0.00213	0.00283	CbGbCtD
Dexamethasone—NOS2—tendon—sarcoma	0.00188	0.0294	CbGeAlD
Dexamethasone—PTGS2—periosteum—sarcoma	0.00138	0.0215	CbGeAlD
Dexamethasone—ANXA1—mammary gland—sarcoma	0.00136	0.0212	CbGeAlD
Dexamethasone—PTGS2—leg—sarcoma	0.0011	0.0171	CbGeAlD
Dexamethasone—PLA2G1B—hematopoietic system—sarcoma	0.00108	0.0169	CbGeAlD
Dexamethasone—PLA2G1B—connective tissue—sarcoma	0.00104	0.0163	CbGeAlD
Dexamethasone—CYP3A43—testis—sarcoma	0.00101	0.0157	CbGeAlD
Dexamethasone—PTGS2—hindlimb—sarcoma	0.00098	0.0153	CbGeAlD
Dexamethasone—ANXA1—myometrium—sarcoma	0.000965	0.0151	CbGeAlD
Dexamethasone—PTGS2—cartilage tissue—sarcoma	0.000964	0.015	CbGeAlD
Dexamethasone—CYP3A43—liver—sarcoma	0.000951	0.0148	CbGeAlD
Dexamethasone—ANXA1—embryo—sarcoma	0.000928	0.0145	CbGeAlD
Dexamethasone—ANXA1—seminal vesicle—sarcoma	0.000872	0.0136	CbGeAlD
Dexamethasone—PTGS2—appendage—sarcoma	0.00084	0.0131	CbGeAlD
Dexamethasone—NR0B1—testis—sarcoma	0.000833	0.013	CbGeAlD
Dexamethasone—ANXA1—hematopoietic system—sarcoma	0.000829	0.0129	CbGeAlD
Dexamethasone—PGR—mammary gland—sarcoma	0.000819	0.0128	CbGeAlD
Dexamethasone—ANXA1—connective tissue—sarcoma	0.000798	0.0124	CbGeAlD
Dexamethasone—ANXA1—smooth muscle tissue—sarcoma	0.00073	0.0114	CbGeAlD
Dexamethasone—ANXA1—skin of body—sarcoma	0.00072	0.0112	CbGeAlD
Dexamethasone—CYP17A1—connective tissue—sarcoma	0.000715	0.0112	CbGeAlD
Dexamethasone—CYP11A1—hematopoietic system—sarcoma	0.000691	0.0108	CbGeAlD
Dexamethasone—CYP1B1—mammary gland—sarcoma	0.000689	0.0107	CbGeAlD
Dexamethasone—CYP4A11—liver—sarcoma	0.000677	0.0106	CbGeAlD
Dexamethasone—CYP11A1—connective tissue—sarcoma	0.000665	0.0104	CbGeAlD
Dexamethasone—ANXA1—cardiac atrium—sarcoma	0.000629	0.00982	CbGeAlD
Dexamethasone—ANXA1—uterus—sarcoma	0.000626	0.00977	CbGeAlD
Dexamethasone—NR3C2—myometrium—sarcoma	0.000625	0.00975	CbGeAlD
Dexamethasone—CYP2A6—seminal vesicle—sarcoma	0.000602	0.0094	CbGeAlD
Dexamethasone—PLA2G1B—testis—sarcoma	0.000594	0.00926	CbGeAlD
Dexamethasone—ANXA1—lymphoid tissue—sarcoma	0.000583	0.0091	CbGeAlD
Dexamethasone—PGR—myometrium—sarcoma	0.000581	0.00906	CbGeAlD
Dexamethasone—NR3C2—seminal vesicle—sarcoma	0.000565	0.00881	CbGeAlD
Dexamethasone—ANXA1—tendon—sarcoma	0.000548	0.00856	CbGeAlD
Dexamethasone—NR3C2—hematopoietic system—sarcoma	0.000537	0.00837	CbGeAlD
Dexamethasone—ANXA1—bone marrow—sarcoma	0.000531	0.00829	CbGeAlD
Dexamethasone—CYP2C8—mammary gland—sarcoma	0.000527	0.00823	CbGeAlD
Dexamethasone—NR3C2—connective tissue—sarcoma	0.000517	0.00806	CbGeAlD
Dexamethasone—PTGS2—endothelium—sarcoma	0.000507	0.00791	CbGeAlD
Dexamethasone—PGR—hematopoietic system—sarcoma	0.000499	0.00778	CbGeAlD
Dexamethasone—PGR—connective tissue—sarcoma	0.00048	0.00749	CbGeAlD
Dexamethasone—NR3C2—smooth muscle tissue—sarcoma	0.000473	0.00737	CbGeAlD
Dexamethasone—CYP2C9—mammary gland—sarcoma	0.000469	0.00731	CbGeAlD
Dexamethasone—ABCB11—testis—sarcoma	0.000462	0.00721	CbGeAlD
Dexamethasone—SLCO1A2—hematopoietic system—sarcoma	0.00046	0.00718	CbGeAlD
Dexamethasone—ANXA1—testis—sarcoma	0.000454	0.00709	CbGeAlD
Dexamethasone—CYP19A1—hematopoietic system—sarcoma	0.000449	0.007	CbGeAlD
Dexamethasone—PGR—smooth muscle tissue—sarcoma	0.000439	0.00685	CbGeAlD
Dexamethasone—ABCB11—liver—sarcoma	0.000437	0.00681	CbGeAlD
Dexamethasone—CYP19A1—connective tissue—sarcoma	0.000432	0.00674	CbGeAlD
Dexamethasone—ANXA1—liver—sarcoma	0.000429	0.0067	CbGeAlD
Dexamethasone—CYP3A7—liver—sarcoma	0.000427	0.00666	CbGeAlD
Dexamethasone—CYP1B1—hematopoietic system—sarcoma	0.00042	0.00655	CbGeAlD
Dexamethasone—NR3C2—cardiac atrium—sarcoma	0.000407	0.00636	CbGeAlD
Dexamethasone—CYP17A1—testis—sarcoma	0.000407	0.00635	CbGeAlD
Dexamethasone—NR3C2—uterus—sarcoma	0.000405	0.00632	CbGeAlD
Dexamethasone—CYP1B1—connective tissue—sarcoma	0.000404	0.0063	CbGeAlD
Dexamethasone—CYP17A1—liver—sarcoma	0.000385	0.006	CbGeAlD
Dexamethasone—CYP11A1—testis—sarcoma	0.000379	0.00591	CbGeAlD
Dexamethasone—PGR—uterus—sarcoma	0.000377	0.00588	CbGeAlD
Dexamethasone—CYP1B1—smooth muscle tissue—sarcoma	0.00037	0.00577	CbGeAlD
Dexamethasone—CYP2C19—hematopoietic system—sarcoma	0.000368	0.00574	CbGeAlD
Dexamethasone—CYP1B1—skin of body—sarcoma	0.000365	0.00569	CbGeAlD
Dexamethasone—ABCG2—myometrium—sarcoma	0.000364	0.00568	CbGeAlD
Dexamethasone—CYP3A7-CYP3A51P—liver—sarcoma	0.000363	0.00566	CbGeAlD
Dexamethasone—NR3C2—tendon—sarcoma	0.000355	0.00554	CbGeAlD
Dexamethasone—PGR—lymphoid tissue—sarcoma	0.000351	0.00548	CbGeAlD
Dexamethasone—CYP19A1—uterus—sarcoma	0.000339	0.00529	CbGeAlD
Dexamethasone—NR3C1—myometrium—sarcoma	0.000335	0.00523	CbGeAlD
Dexamethasone—ANXA1—lymph node—sarcoma	0.000329	0.00514	CbGeAlD
Dexamethasone—ABCG2—seminal vesicle—sarcoma	0.000329	0.00513	CbGeAlD
Dexamethasone—NR3C1—embryo—sarcoma	0.000322	0.00503	CbGeAlD
Dexamethasone—CYP2C8—hematopoietic system—sarcoma	0.000321	0.00501	CbGeAlD
Dexamethasone—CYP1B1—uterus—sarcoma	0.000317	0.00495	CbGeAlD
Dexamethasone—NR3C1—seminal vesicle—sarcoma	0.000303	0.00473	CbGeAlD
Dexamethasone—CYP1A1—hematopoietic system—sarcoma	0.000297	0.00463	CbGeAlD
Dexamethasone—CYP2A6—liver—sarcoma	0.000297	0.00463	CbGeAlD
Dexamethasone—CYP1B1—lymphoid tissue—sarcoma	0.000295	0.00461	CbGeAlD
Dexamethasone—CYP17A1—lymph node—sarcoma	0.000295	0.0046	CbGeAlD
Dexamethasone—NR3C2—testis—sarcoma	0.000294	0.00459	CbGeAlD
Dexamethasone—PTGS2—myometrium—sarcoma	0.00029	0.00453	CbGeAlD
Dexamethasone—CYP3A5—hematopoietic system—sarcoma	0.00029	0.00453	CbGeAlD
Dexamethasone—CYP2B6—hematopoietic system—sarcoma	0.000288	0.0045	CbGeAlD
Dexamethasone—NR3C1—hematopoietic system—sarcoma	0.000288	0.00449	CbGeAlD
Dexamethasone—CYP2C9—hematopoietic system—sarcoma	0.000285	0.00445	CbGeAlD
Dexamethasone—CYP2E1—seminal vesicle—sarcoma	0.000285	0.00444	CbGeAlD
Dexamethasone—ABCC2—tendon—sarcoma	0.000284	0.00442	CbGeAlD
Dexamethasone—PTGS2—embryo—sarcoma	0.000279	0.00435	CbGeAlD
Dexamethasone—NR3C2—liver—sarcoma	0.000278	0.00434	CbGeAlD
Dexamethasone—CYP1B1—tendon—sarcoma	0.000278	0.00433	CbGeAlD
Dexamethasone—NR3C1—connective tissue—sarcoma	0.000277	0.00432	CbGeAlD
Dexamethasone—CYP11A1—lymph node—sarcoma	0.000274	0.00428	CbGeAlD
Dexamethasone—PGR—testis—sarcoma	0.000273	0.00426	CbGeAlD
Dexamethasone—CYP2E1—hematopoietic system—sarcoma	0.000271	0.00422	CbGeAlD
Dexamethasone—PTGS2—seminal vesicle—sarcoma	0.000262	0.00409	CbGeAlD
Dexamethasone—CYP1A1—skin of body—sarcoma	0.000258	0.00402	CbGeAlD
Dexamethasone—NR3C1—smooth muscle tissue—sarcoma	0.000254	0.00396	CbGeAlD
Dexamethasone—SLCO1A2—testis—sarcoma	0.000252	0.00393	CbGeAlD
Dexamethasone—CYP2B6—skin of body—sarcoma	0.000251	0.00391	CbGeAlD
Dexamethasone—NR3C1—skin of body—sarcoma	0.00025	0.0039	CbGeAlD
Dexamethasone—PTGS2—hematopoietic system—sarcoma	0.000249	0.00389	CbGeAlD
Dexamethasone—CYP19A1—testis—sarcoma	0.000246	0.00384	CbGeAlD
Dexamethasone—PTGS2—connective tissue—sarcoma	0.00024	0.00374	CbGeAlD
Dexamethasone—SLCO1A2—liver—sarcoma	0.000238	0.00372	CbGeAlD
Dexamethasone—ABCG2—uterus—sarcoma	0.000236	0.00368	CbGeAlD
Dexamethasone—ABCC2—testis—sarcoma	0.000235	0.00366	CbGeAlD
Dexamethasone—CYP19A1—liver—sarcoma	0.000233	0.00363	CbGeAlD
Dexamethasone—CYP1B1—testis—sarcoma	0.00023	0.00359	CbGeAlD
Dexamethasone—CYP1A1—cardiac atrium—sarcoma	0.000225	0.00351	CbGeAlD
Dexamethasone—CYP1A1—uterus—sarcoma	0.000224	0.0035	CbGeAlD
Dexamethasone—ABCC2—liver—sarcoma	0.000222	0.00346	CbGeAlD
Dexamethasone—PTGS2—smooth muscle tissue—sarcoma	0.000219	0.00342	CbGeAlD
Dexamethasone—NR3C1—cardiac atrium—sarcoma	0.000219	0.00341	CbGeAlD
Dexamethasone—CYP3A4—hematopoietic system—sarcoma	0.000218	0.0034	CbGeAlD
Dexamethasone—CYP1B1—liver—sarcoma	0.000217	0.00339	CbGeAlD
Dexamethasone—NR3C1—uterus—sarcoma	0.000217	0.00339	CbGeAlD
Dexamethasone—PTGS2—skin of body—sarcoma	0.000217	0.00338	CbGeAlD
Dexamethasone—CYP2D6—hematopoietic system—sarcoma	0.000214	0.00334	CbGeAlD
Dexamethasone—NR3C2—lymph node—sarcoma	0.000213	0.00333	CbGeAlD
Dexamethasone—CYP2B6—lymphoid tissue—sarcoma	0.000203	0.00317	CbGeAlD
Dexamethasone—NR3C1—lymphoid tissue—sarcoma	0.000203	0.00316	CbGeAlD
Dexamethasone—ABCG2—bone marrow—sarcoma	0.0002	0.00313	CbGeAlD
Dexamethasone—PGR—lymph node—sarcoma	0.000198	0.00309	CbGeAlD
Dexamethasone—CYP2C19—liver—sarcoma	0.000191	0.00298	CbGeAlD
Dexamethasone—NR3C1—tendon—sarcoma	0.00019	0.00297	CbGeAlD
Dexamethasone—CYP2E1—lymphoid tissue—sarcoma	0.00019	0.00297	CbGeAlD
Dexamethasone—PTGS2—uterus—sarcoma	0.000188	0.00294	CbGeAlD
Dexamethasone—NR3C1—bone marrow—sarcoma	0.000185	0.00288	CbGeAlD
Dexamethasone—ABCB1—myometrium—sarcoma	0.000179	0.0028	CbGeAlD
Dexamethasone—CYP2E1—tendon—sarcoma	0.000179	0.00279	CbGeAlD
Dexamethasone—Thrombocytopenia—Vincristine—sarcoma	0.000179	0.00156	CcSEcCtD
Dexamethasone—CYP19A1—lymph node—sarcoma	0.000178	0.00278	CbGeAlD
Dexamethasone—Anaphylactic shock—Mitoxantrone—sarcoma	0.000178	0.00155	CcSEcCtD
Dexamethasone—Oedema—Mitoxantrone—sarcoma	0.000178	0.00155	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Thiotepa—sarcoma	0.000178	0.00155	CcSEcCtD
Dexamethasone—Decreased appetite—Dactinomycin—sarcoma	0.000178	0.00155	CcSEcCtD
Dexamethasone—Fatigue—Thiotepa—sarcoma	0.000178	0.00155	CcSEcCtD
Dexamethasone—Infection—Mitoxantrone—sarcoma	0.000177	0.00154	CcSEcCtD
Dexamethasone—Hyperhidrosis—Vincristine—sarcoma	0.000177	0.00154	CcSEcCtD
Dexamethasone—Dermatitis bullous—Epirubicin—sarcoma	0.000177	0.00154	CcSEcCtD
Dexamethasone—Fatigue—Dactinomycin—sarcoma	0.000176	0.00154	CcSEcCtD
Dexamethasone—Pain—Thiotepa—sarcoma	0.000176	0.00154	CcSEcCtD
Dexamethasone—CYP2C8—testis—sarcoma	0.000176	0.00275	CbGeAlD
Dexamethasone—PTGS2—lymphoid tissue—sarcoma	0.000175	0.00274	CbGeAlD
Dexamethasone—Shock—Mitoxantrone—sarcoma	0.000175	0.00153	CcSEcCtD
Dexamethasone—Pain—Dactinomycin—sarcoma	0.000175	0.00153	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Epirubicin—sarcoma	0.000174	0.00152	CcSEcCtD
Dexamethasone—Thrombocytopenia—Mitoxantrone—sarcoma	0.000174	0.00152	CcSEcCtD
Dexamethasone—Anorexia—Vincristine—sarcoma	0.000174	0.00152	CcSEcCtD
Dexamethasone—Tachycardia—Mitoxantrone—sarcoma	0.000174	0.00152	CcSEcCtD
Dexamethasone—Eye pain—Doxorubicin—sarcoma	0.000173	0.00151	CcSEcCtD
Dexamethasone—Cardiac failure—Epirubicin—sarcoma	0.000173	0.00151	CcSEcCtD
Dexamethasone—ABCB1—embryo—sarcoma	0.000173	0.00269	CbGeAlD
Dexamethasone—Lethargy—Epirubicin—sarcoma	0.000172	0.0015	CcSEcCtD
Dexamethasone—Cardiac failure congestive—Doxorubicin—sarcoma	0.000172	0.0015	CcSEcCtD
Dexamethasone—Hyperhidrosis—Mitoxantrone—sarcoma	0.000172	0.0015	CcSEcCtD
Dexamethasone—ABCG2—testis—sarcoma	0.000171	0.00267	CbGeAlD
Dexamethasone—Hypotension—Vincristine—sarcoma	0.000171	0.00149	CcSEcCtD
Dexamethasone—ABCC2—lymph node—sarcoma	0.00017	0.00266	CbGeAlD
Dexamethasone—Feeling abnormal—Thiotepa—sarcoma	0.00017	0.00148	CcSEcCtD
Dexamethasone—Anorexia—Mitoxantrone—sarcoma	0.00017	0.00148	CcSEcCtD
Dexamethasone—Osteoarthritis—Epirubicin—sarcoma	0.000169	0.00147	CcSEcCtD
Dexamethasone—Feeling abnormal—Dactinomycin—sarcoma	0.000168	0.00147	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Thiotepa—sarcoma	0.000168	0.00147	CcSEcCtD
Dexamethasone—Ill-defined disorder—Etoposide—sarcoma	0.000168	0.00147	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Dactinomycin—sarcoma	0.000167	0.00146	CcSEcCtD
Dexamethasone—CYP1B1—lymph node—sarcoma	0.000167	0.0026	CbGeAlD
Dexamethasone—CYP2C8—liver—sarcoma	0.000166	0.0026	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Vincristine—sarcoma	0.000166	0.00145	CcSEcCtD
Dexamethasone—Hypotension—Mitoxantrone—sarcoma	0.000166	0.00145	CcSEcCtD
Dexamethasone—Increased appetite—Doxorubicin—sarcoma	0.000166	0.00145	CcSEcCtD
Dexamethasone—Affect lability—Epirubicin—sarcoma	0.000166	0.00145	CcSEcCtD
Dexamethasone—Migraine—Epirubicin—sarcoma	0.000166	0.00145	CcSEcCtD
Dexamethasone—Insomnia—Vincristine—sarcoma	0.000165	0.00144	CcSEcCtD
Dexamethasone—PTGS2—tendon—sarcoma	0.000165	0.00257	CbGeAlD
Dexamethasone—Paraesthesia—Vincristine—sarcoma	0.000164	0.00143	CcSEcCtD
Dexamethasone—Urticaria—Thiotepa—sarcoma	0.000164	0.00143	CcSEcCtD
Dexamethasone—Malaise—Etoposide—sarcoma	0.000163	0.00143	CcSEcCtD
Dexamethasone—Dermatitis bullous—Doxorubicin—sarcoma	0.000163	0.00143	CcSEcCtD
Dexamethasone—Vertigo—Etoposide—sarcoma	0.000163	0.00142	CcSEcCtD
Dexamethasone—Abdominal pain—Thiotepa—sarcoma	0.000163	0.00142	CcSEcCtD
Dexamethasone—Body temperature increased—Thiotepa—sarcoma	0.000163	0.00142	CcSEcCtD
Dexamethasone—ABCB1—seminal vesicle—sarcoma	0.000162	0.00253	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000162	0.00141	CcSEcCtD
Dexamethasone—ABCG2—liver—sarcoma	0.000162	0.00253	CbGeAlD
Dexamethasone—Body temperature increased—Dactinomycin—sarcoma	0.000162	0.00141	CcSEcCtD
Dexamethasone—Abdominal pain—Dactinomycin—sarcoma	0.000162	0.00141	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000161	0.00141	CcSEcCtD
Dexamethasone—Cardiac arrest—Epirubicin—sarcoma	0.00016	0.0014	CcSEcCtD
Dexamethasone—Cardiac failure—Doxorubicin—sarcoma	0.00016	0.0014	CcSEcCtD
Dexamethasone—Mood swings—Epirubicin—sarcoma	0.00016	0.0014	CcSEcCtD
Dexamethasone—Paraesthesia—Mitoxantrone—sarcoma	0.00016	0.00139	CcSEcCtD
Dexamethasone—PTGS2—bone marrow—sarcoma	0.00016	0.00249	CbGeAlD
Dexamethasone—Loss of consciousness—Etoposide—sarcoma	0.000159	0.00139	CcSEcCtD
Dexamethasone—Lethargy—Doxorubicin—sarcoma	0.000159	0.00139	CcSEcCtD
Dexamethasone—Decreased appetite—Vincristine—sarcoma	0.000159	0.00139	CcSEcCtD
Dexamethasone—CYP2B6—testis—sarcoma	0.000158	0.00246	CbGeAlD
Dexamethasone—NR3C1—testis—sarcoma	0.000158	0.00246	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Vincristine—sarcoma	0.000158	0.00138	CcSEcCtD
Dexamethasone—Fatigue—Vincristine—sarcoma	0.000157	0.00137	CcSEcCtD
Dexamethasone—Convulsion—Etoposide—sarcoma	0.000157	0.00137	CcSEcCtD
Dexamethasone—Dyspepsia—Mitoxantrone—sarcoma	0.000157	0.00137	CcSEcCtD
Dexamethasone—Hypertension—Etoposide—sarcoma	0.000156	0.00137	CcSEcCtD
Dexamethasone—Pain—Vincristine—sarcoma	0.000156	0.00136	CcSEcCtD
Dexamethasone—Osteoarthritis—Doxorubicin—sarcoma	0.000156	0.00136	CcSEcCtD
Dexamethasone—Dry skin—Epirubicin—sarcoma	0.000155	0.00135	CcSEcCtD
Dexamethasone—Decreased appetite—Mitoxantrone—sarcoma	0.000155	0.00135	CcSEcCtD
Dexamethasone—ABCB1—hematopoietic system—sarcoma	0.000154	0.0024	CbGeAlD
Dexamethasone—CYP1A1—liver—sarcoma	0.000154	0.0024	CbGeAlD
Dexamethasone—Affect lability—Doxorubicin—sarcoma	0.000154	0.00134	CcSEcCtD
Dexamethasone—Migraine—Doxorubicin—sarcoma	0.000154	0.00134	CcSEcCtD
Dexamethasone—Hypokalaemia—Epirubicin—sarcoma	0.000154	0.00134	CcSEcCtD
Dexamethasone—Fatigue—Mitoxantrone—sarcoma	0.000153	0.00134	CcSEcCtD
Dexamethasone—Discomfort—Etoposide—sarcoma	0.000152	0.00133	CcSEcCtD
Dexamethasone—Pain—Mitoxantrone—sarcoma	0.000152	0.00133	CcSEcCtD
Dexamethasone—CYP3A5—liver—sarcoma	0.00015	0.00234	CbGeAlD
Dexamethasone—CYP2B6—liver—sarcoma	0.000149	0.00233	CbGeAlD
Dexamethasone—Gastrointestinal pain—Vincristine—sarcoma	0.000149	0.0013	CcSEcCtD
Dexamethasone—NR3C1—liver—sarcoma	0.000149	0.00233	CbGeAlD
Dexamethasone—Muscular weakness—Epirubicin—sarcoma	0.000149	0.0013	CcSEcCtD
Dexamethasone—Cardiac arrest—Doxorubicin—sarcoma	0.000148	0.0013	CcSEcCtD
Dexamethasone—CYP2E1—testis—sarcoma	0.000148	0.00231	CbGeAlD
Dexamethasone—Anaphylactic shock—Etoposide—sarcoma	0.000148	0.00129	CcSEcCtD
Dexamethasone—CYP2C9—liver—sarcoma	0.000148	0.00231	CbGeAlD
Dexamethasone—Mood swings—Doxorubicin—sarcoma	0.000148	0.00129	CcSEcCtD
Dexamethasone—Asthenia—Thiotepa—sarcoma	0.000148	0.00129	CcSEcCtD
Dexamethasone—Infection—Etoposide—sarcoma	0.000147	0.00128	CcSEcCtD
Dexamethasone—Asthenia—Dactinomycin—sarcoma	0.000147	0.00128	CcSEcCtD
Dexamethasone—Feeling abnormal—Mitoxantrone—sarcoma	0.000147	0.00128	CcSEcCtD
Dexamethasone—Pruritus—Thiotepa—sarcoma	0.000146	0.00127	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000145	0.00127	CcSEcCtD
Dexamethasone—Thrombocytopenia—Etoposide—sarcoma	0.000145	0.00126	CcSEcCtD
Dexamethasone—Tachycardia—Etoposide—sarcoma	0.000144	0.00126	CcSEcCtD
Dexamethasone—Abdominal pain—Vincristine—sarcoma	0.000144	0.00126	CcSEcCtD
Dexamethasone—Body temperature increased—Vincristine—sarcoma	0.000144	0.00126	CcSEcCtD
Dexamethasone—Dry skin—Doxorubicin—sarcoma	0.000143	0.00125	CcSEcCtD
Dexamethasone—Hyperhidrosis—Etoposide—sarcoma	0.000143	0.00125	CcSEcCtD
Dexamethasone—Hypokalaemia—Doxorubicin—sarcoma	0.000142	0.00124	CcSEcCtD
Dexamethasone—Urticaria—Mitoxantrone—sarcoma	0.000141	0.00123	CcSEcCtD
Dexamethasone—Anorexia—Etoposide—sarcoma	0.000141	0.00123	CcSEcCtD
Dexamethasone—Diarrhoea—Thiotepa—sarcoma	0.000141	0.00123	CcSEcCtD
Dexamethasone—Body temperature increased—Mitoxantrone—sarcoma	0.000141	0.00123	CcSEcCtD
Dexamethasone—Abdominal pain—Mitoxantrone—sarcoma	0.000141	0.00123	CcSEcCtD
Dexamethasone—CYP2E1—liver—sarcoma	0.00014	0.00219	CbGeAlD
Dexamethasone—Diarrhoea—Dactinomycin—sarcoma	0.00014	0.00122	CcSEcCtD
Dexamethasone—Hypotension—Etoposide—sarcoma	0.000138	0.00121	CcSEcCtD
Dexamethasone—Muscular weakness—Doxorubicin—sarcoma	0.000138	0.0012	CcSEcCtD
Dexamethasone—Dizziness—Thiotepa—sarcoma	0.000136	0.00119	CcSEcCtD
Dexamethasone—Paraesthesia—Etoposide—sarcoma	0.000133	0.00116	CcSEcCtD
Dexamethasone—Weight increased—Epirubicin—sarcoma	0.000133	0.00116	CcSEcCtD
Dexamethasone—Weight decreased—Epirubicin—sarcoma	0.000132	0.00115	CcSEcCtD
Dexamethasone—Hyperglycaemia—Epirubicin—sarcoma	0.000132	0.00115	CcSEcCtD
Dexamethasone—Asthenia—Vincristine—sarcoma	0.000131	0.00114	CcSEcCtD
Dexamethasone—Vomiting—Thiotepa—sarcoma	0.000131	0.00114	CcSEcCtD
Dexamethasone—Vomiting—Dactinomycin—sarcoma	0.00013	0.00113	CcSEcCtD
Dexamethasone—Rash—Thiotepa—sarcoma	0.00013	0.00113	CcSEcCtD
Dexamethasone—Dermatitis—Thiotepa—sarcoma	0.00013	0.00113	CcSEcCtD
Dexamethasone—PTGS2—liver—sarcoma	0.000129	0.00201	CbGeAlD
Dexamethasone—Headache—Thiotepa—sarcoma	0.000129	0.00113	CcSEcCtD
Dexamethasone—Rash—Dactinomycin—sarcoma	0.000129	0.00113	CcSEcCtD
Dexamethasone—Decreased appetite—Etoposide—sarcoma	0.000129	0.00112	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Etoposide—sarcoma	0.000128	0.00112	CcSEcCtD
Dexamethasone—Asthenia—Mitoxantrone—sarcoma	0.000128	0.00111	CcSEcCtD
Dexamethasone—Fatigue—Etoposide—sarcoma	0.000128	0.00111	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Epirubicin—sarcoma	0.000127	0.00111	CcSEcCtD
Dexamethasone—Pain—Etoposide—sarcoma	0.000127	0.0011	CcSEcCtD
Dexamethasone—Conjunctivitis—Epirubicin—sarcoma	0.000126	0.0011	CcSEcCtD
Dexamethasone—Diarrhoea—Vincristine—sarcoma	0.000125	0.00109	CcSEcCtD
Dexamethasone—ABCG2—lymph node—sarcoma	0.000124	0.00194	CbGeAlD
Dexamethasone—Weight increased—Doxorubicin—sarcoma	0.000123	0.00107	CcSEcCtD
Dexamethasone—Nausea—Thiotepa—sarcoma	0.000122	0.00107	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—sarcoma	0.000122	0.00107	CcSEcCtD
Dexamethasone—Feeling abnormal—Etoposide—sarcoma	0.000122	0.00106	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—sarcoma	0.000122	0.00106	CcSEcCtD
Dexamethasone—Diarrhoea—Mitoxantrone—sarcoma	0.000122	0.00106	CcSEcCtD
Dexamethasone—Nausea—Dactinomycin—sarcoma	0.000121	0.00106	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Etoposide—sarcoma	0.000121	0.00106	CcSEcCtD
Dexamethasone—Dizziness—Vincristine—sarcoma	0.000121	0.00105	CcSEcCtD
Dexamethasone—Bradycardia—Epirubicin—sarcoma	0.000119	0.00104	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—sarcoma	0.000118	0.00103	CcSEcCtD
Dexamethasone—CYP1A1—lymph node—sarcoma	0.000118	0.00184	CbGeAlD
Dexamethasone—Urticaria—Etoposide—sarcoma	0.000118	0.00103	CcSEcCtD
Dexamethasone—CYP2D6—testis—sarcoma	0.000117	0.00183	CbGeAlD
Dexamethasone—Haemoglobin—Epirubicin—sarcoma	0.000117	0.00102	CcSEcCtD
Dexamethasone—Body temperature increased—Etoposide—sarcoma	0.000117	0.00102	CcSEcCtD
Dexamethasone—Abdominal pain—Etoposide—sarcoma	0.000117	0.00102	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—sarcoma	0.000117	0.00102	CcSEcCtD
Dexamethasone—Haemorrhage—Epirubicin—sarcoma	0.000117	0.00102	CcSEcCtD
Dexamethasone—ABCB1—uterus—sarcoma	0.000116	0.00182	CbGeAlD
Dexamethasone—Vomiting—Vincristine—sarcoma	0.000116	0.00101	CcSEcCtD
Dexamethasone—Rash—Vincristine—sarcoma	0.000115	0.00101	CcSEcCtD
Dexamethasone—Dermatitis—Vincristine—sarcoma	0.000115	0.001	CcSEcCtD
Dexamethasone—Headache—Vincristine—sarcoma	0.000114	0.000999	CcSEcCtD
Dexamethasone—NR3C1—lymph node—sarcoma	0.000114	0.00178	CbGeAlD
Dexamethasone—Vomiting—Mitoxantrone—sarcoma	0.000113	0.000987	CcSEcCtD
Dexamethasone—CYP3A4—liver—sarcoma	0.000113	0.00176	CbGeAlD
Dexamethasone—Visual impairment—Epirubicin—sarcoma	0.000112	0.000982	CcSEcCtD
Dexamethasone—Rash—Mitoxantrone—sarcoma	0.000112	0.000979	CcSEcCtD
Dexamethasone—Dermatitis—Mitoxantrone—sarcoma	0.000112	0.000978	CcSEcCtD
Dexamethasone—Headache—Mitoxantrone—sarcoma	0.000111	0.000973	CcSEcCtD
Dexamethasone—CYP2D6—liver—sarcoma	0.000111	0.00173	CbGeAlD
Dexamethasone—Bradycardia—Doxorubicin—sarcoma	0.00011	0.00096	CcSEcCtD
Dexamethasone—Eye disorder—Epirubicin—sarcoma	0.000109	0.000952	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—sarcoma	0.000109	0.000948	CcSEcCtD
Dexamethasone—ABCB1—lymphoid tissue—sarcoma	0.000108	0.00169	CbGeAlD
Dexamethasone—Nausea—Vincristine—sarcoma	0.000108	0.000947	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—sarcoma	0.000108	0.000943	CcSEcCtD
Dexamethasone—Asthenia—Etoposide—sarcoma	0.000106	0.000927	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—sarcoma	0.000106	0.000925	CcSEcCtD
Dexamethasone—Nausea—Mitoxantrone—sarcoma	0.000106	0.000922	CcSEcCtD
Dexamethasone—Pruritus—Etoposide—sarcoma	0.000105	0.000914	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—sarcoma	0.000104	0.00091	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—sarcoma	0.000104	0.000909	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—sarcoma	0.000103	0.000901	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—sarcoma	0.000102	0.000887	CcSEcCtD
Dexamethasone—Diarrhoea—Etoposide—sarcoma	0.000101	0.000884	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—sarcoma	0.000101	0.000881	CcSEcCtD
Dexamethasone—PTGS2—lymph node—sarcoma	9.89e-05	0.00154	CbGeAlD
Dexamethasone—ABCB1—bone marrow—sarcoma	9.88e-05	0.00154	CbGeAlD
Dexamethasone—Angiopathy—Doxorubicin—sarcoma	9.8e-05	0.000856	CcSEcCtD
Dexamethasone—Dizziness—Etoposide—sarcoma	9.78e-05	0.000854	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—sarcoma	9.65e-05	0.000842	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—sarcoma	9.54e-05	0.000833	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—sarcoma	9.43e-05	0.000823	CcSEcCtD
Dexamethasone—Vomiting—Etoposide—sarcoma	9.41e-05	0.000821	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—sarcoma	9.4e-05	0.000821	CcSEcCtD
Dexamethasone—Rash—Etoposide—sarcoma	9.33e-05	0.000814	CcSEcCtD
Dexamethasone—Dermatitis—Etoposide—sarcoma	9.32e-05	0.000814	CcSEcCtD
Dexamethasone—Headache—Etoposide—sarcoma	9.27e-05	0.000809	CcSEcCtD
Dexamethasone—Malaise—Epirubicin—sarcoma	9.16e-05	0.0008	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—sarcoma	9.13e-05	0.000797	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—sarcoma	9.11e-05	0.000796	CcSEcCtD
Dexamethasone—Loss of consciousness—Epirubicin—sarcoma	8.93e-05	0.00078	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—sarcoma	8.8e-05	0.000769	CcSEcCtD
Dexamethasone—Nausea—Etoposide—sarcoma	8.79e-05	0.000767	CcSEcCtD
Dexamethasone—Hypertension—Epirubicin—sarcoma	8.77e-05	0.000766	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—sarcoma	8.72e-05	0.000762	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—sarcoma	8.65e-05	0.000755	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—sarcoma	8.62e-05	0.000753	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—sarcoma	8.55e-05	0.000746	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—sarcoma	8.48e-05	0.00074	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—sarcoma	8.45e-05	0.000738	CcSEcCtD
Dexamethasone—ABCB1—testis—sarcoma	8.44e-05	0.00132	CbGeAlD
Dexamethasone—Syncope—Doxorubicin—sarcoma	8.43e-05	0.000736	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—sarcoma	8.29e-05	0.000724	CcSEcCtD
Dexamethasone—Oedema—Epirubicin—sarcoma	8.29e-05	0.000724	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—sarcoma	8.26e-05	0.000722	CcSEcCtD
Dexamethasone—Infection—Epirubicin—sarcoma	8.24e-05	0.000719	CcSEcCtD
Dexamethasone—Shock—Epirubicin—sarcoma	8.16e-05	0.000712	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—sarcoma	8.15e-05	0.000711	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—sarcoma	8.13e-05	0.00071	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—sarcoma	8.12e-05	0.000709	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—sarcoma	8.12e-05	0.000709	CcSEcCtD
Dexamethasone—Tachycardia—Epirubicin—sarcoma	8.09e-05	0.000707	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—sarcoma	8.02e-05	0.0007	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—sarcoma	8e-05	0.000699	CcSEcCtD
Dexamethasone—ABCB1—liver—sarcoma	7.98e-05	0.00125	CbGeAlD
Dexamethasone—Anxiety—Doxorubicin—sarcoma	7.98e-05	0.000696	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—sarcoma	7.91e-05	0.000691	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—sarcoma	7.9e-05	0.00069	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—sarcoma	7.75e-05	0.000677	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—sarcoma	7.67e-05	0.00067	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—sarcoma	7.67e-05	0.00067	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—sarcoma	7.62e-05	0.000666	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—sarcoma	7.56e-05	0.00066	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—sarcoma	7.55e-05	0.000659	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—sarcoma	7.52e-05	0.000657	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—sarcoma	7.51e-05	0.000656	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—sarcoma	7.5e-05	0.000655	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—sarcoma	7.49e-05	0.000654	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—sarcoma	7.45e-05	0.00065	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—sarcoma	7.42e-05	0.000648	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—sarcoma	7.31e-05	0.000639	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—sarcoma	7.3e-05	0.000637	CcSEcCtD
Dexamethasone—Decreased appetite—Epirubicin—sarcoma	7.21e-05	0.000629	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—sarcoma	7.17e-05	0.000626	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—sarcoma	7.16e-05	0.000625	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—sarcoma	7.15e-05	0.000624	CcSEcCtD
Dexamethasone—Pain—Epirubicin—sarcoma	7.09e-05	0.000619	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—sarcoma	6.99e-05	0.00061	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—sarcoma	6.94e-05	0.000606	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—sarcoma	6.89e-05	0.000602	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—sarcoma	6.83e-05	0.000597	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—sarcoma	6.78e-05	0.000592	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—sarcoma	6.75e-05	0.00059	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—sarcoma	6.67e-05	0.000582	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—sarcoma	6.62e-05	0.000578	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—sarcoma	6.62e-05	0.000578	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—sarcoma	6.59e-05	0.000575	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—sarcoma	6.56e-05	0.000573	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—sarcoma	6.56e-05	0.000572	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—sarcoma	6.56e-05	0.000572	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—sarcoma	6.32e-05	0.000552	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—sarcoma	6.27e-05	0.000548	CcSEcCtD
Dexamethasone—ABCB1—lymph node—sarcoma	6.12e-05	0.000955	CbGeAlD
Dexamethasone—Urticaria—Doxorubicin—sarcoma	6.1e-05	0.000532	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—sarcoma	6.07e-05	0.00053	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—sarcoma	6.07e-05	0.00053	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—sarcoma	5.95e-05	0.00052	CcSEcCtD
Dexamethasone—Pruritus—Epirubicin—sarcoma	5.87e-05	0.000512	CcSEcCtD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	5.7e-05	0.000846	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—HBA1—sarcoma	5.68e-05	0.000843	CbGpPWpGaD
Dexamethasone—Diarrhoea—Epirubicin—sarcoma	5.67e-05	0.000495	CcSEcCtD
Dexamethasone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	5.64e-05	0.000838	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	5.63e-05	0.000836	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—MYC—sarcoma	5.57e-05	0.000827	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—NRAS—sarcoma	5.57e-05	0.000826	CbGpPWpGaD
Dexamethasone—Asthenia—Doxorubicin—sarcoma	5.51e-05	0.000481	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—sarcoma	5.48e-05	0.000479	CcSEcCtD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	5.46e-05	0.000811	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	5.43e-05	0.000806	CbGpPWpGaD
Dexamethasone—Pruritus—Doxorubicin—sarcoma	5.43e-05	0.000474	CcSEcCtD
Dexamethasone—Vomiting—Epirubicin—sarcoma	5.27e-05	0.00046	CcSEcCtD
Dexamethasone—ANXA1—Signaling Pathways—VEGFC—sarcoma	5.25e-05	0.00078	CbGpPWpGaD
Dexamethasone—Diarrhoea—Doxorubicin—sarcoma	5.25e-05	0.000458	CcSEcCtD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—MYC—sarcoma	5.24e-05	0.000779	CbGpPWpGaD
Dexamethasone—NOS2—Disease—ENO2—sarcoma	5.24e-05	0.000778	CbGpPWpGaD
Dexamethasone—Rash—Epirubicin—sarcoma	5.23e-05	0.000457	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—sarcoma	5.22e-05	0.000456	CcSEcCtD
Dexamethasone—Headache—Epirubicin—sarcoma	5.19e-05	0.000454	CcSEcCtD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	5.13e-05	0.000762	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	5.13e-05	0.000762	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—CREB1—sarcoma	5.08e-05	0.000754	CbGpPWpGaD
Dexamethasone—Dizziness—Doxorubicin—sarcoma	5.07e-05	0.000443	CcSEcCtD
Dexamethasone—PGR—Signaling by ERBB4—EGFR—sarcoma	5.07e-05	0.000753	CbGpPWpGaD
Dexamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	4.96e-05	0.000736	CbGpPWpGaD
Dexamethasone—Nausea—Epirubicin—sarcoma	4.93e-05	0.00043	CcSEcCtD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—sarcoma	4.89e-05	0.000726	CbGpPWpGaD
Dexamethasone—Vomiting—Doxorubicin—sarcoma	4.88e-05	0.000426	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism—PLCG1—sarcoma	4.85e-05	0.00072	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	4.85e-05	0.00072	CbGpPWpGaD
Dexamethasone—Rash—Doxorubicin—sarcoma	4.84e-05	0.000422	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—sarcoma	4.83e-05	0.000422	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—sarcoma	4.81e-05	0.00042	CcSEcCtD
Dexamethasone—PGR—Signaling by ERBB4—KRAS—sarcoma	4.79e-05	0.000711	CbGpPWpGaD
Dexamethasone—NOS2—Circadian rythm related genes—TP53—sarcoma	4.7e-05	0.000697	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	4.64e-05	0.000689	CbGpPWpGaD
Dexamethasone—NR0B1—Generic Transcription Pathway—MYC—sarcoma	4.61e-05	0.000685	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—FUS—sarcoma	4.59e-05	0.000682	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—TP53—sarcoma	4.58e-05	0.00068	CbGpPWpGaD
Dexamethasone—Nausea—Doxorubicin—sarcoma	4.56e-05	0.000398	CcSEcCtD
Dexamethasone—PTGS2—C-MYB transcription factor network—CCND1—sarcoma	4.55e-05	0.000676	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—ENO2—sarcoma	4.5e-05	0.000668	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—HBA1—sarcoma	4.47e-05	0.000664	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PLCG1—sarcoma	4.45e-05	0.00066	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	4.43e-05	0.000658	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CXCR4—sarcoma	4.27e-05	0.000634	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—sarcoma	4.26e-05	0.000633	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—JUN—sarcoma	4.25e-05	0.000631	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	4.22e-05	0.000626	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—FLT1—sarcoma	4.2e-05	0.000624	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—CTNNB1—sarcoma	4.19e-05	0.000623	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PLCG1—sarcoma	4.13e-05	0.000613	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	4.12e-05	0.000612	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—HRAS—sarcoma	4.07e-05	0.000605	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—sarcoma	4.03e-05	0.000599	CbGpPWpGaD
Dexamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	3.98e-05	0.000591	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CXCR4—sarcoma	3.97e-05	0.000589	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ATF1—sarcoma	3.92e-05	0.000582	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—NRAS—sarcoma	3.92e-05	0.000582	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	3.9e-05	0.00058	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PLCG1—sarcoma	3.82e-05	0.000567	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	3.71e-05	0.000551	CbGpPWpGaD
Dexamethasone—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	3.69e-05	0.000548	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—JUN—sarcoma	3.65e-05	0.000542	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—MYC—sarcoma	3.65e-05	0.000542	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	3.62e-05	0.000538	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CREB1—sarcoma	3.6e-05	0.000534	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—IL2—sarcoma	3.56e-05	0.000528	CbGpPWpGaD
Dexamethasone—NR3C2—Generic Transcription Pathway—MYC—sarcoma	3.52e-05	0.000523	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—IL2—sarcoma	3.5e-05	0.000519	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IL2—sarcoma	3.48e-05	0.000516	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—CCND1—sarcoma	3.47e-05	0.000515	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—ENO2—sarcoma	3.44e-05	0.000511	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—HBA1—sarcoma	3.42e-05	0.000508	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—MYC—sarcoma	3.42e-05	0.000507	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	3.41e-05	0.000506	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TLE1—sarcoma	3.41e-05	0.000506	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—KRAS—sarcoma	3.37e-05	0.000501	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—sarcoma	3.34e-05	0.000496	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	3.27e-05	0.000486	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—sarcoma	3.19e-05	0.000474	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—sarcoma	3.16e-05	0.000469	CbGpPWpGaD
Dexamethasone—NOS2—Disease—FOXO1—sarcoma	3.16e-05	0.000469	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PDGFRB—sarcoma	3.15e-05	0.000468	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—ENO2—sarcoma	3.15e-05	0.000468	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	3.14e-05	0.000467	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—HBA1—sarcoma	3.13e-05	0.000465	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—ENO2—sarcoma	3.12e-05	0.000463	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PDGFRA—sarcoma	3.1e-05	0.00046	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—HBA1—sarcoma	3.1e-05	0.00046	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IGF1R—sarcoma	3.08e-05	0.000457	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—SRC—sarcoma	3.05e-05	0.000453	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—VEGFA—sarcoma	2.97e-05	0.000441	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—VEGFA—sarcoma	2.95e-05	0.000439	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—NRAS—sarcoma	2.93e-05	0.000436	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—FOXO1—sarcoma	2.93e-05	0.000435	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—IL2—sarcoma	2.93e-05	0.000435	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PDGFRB—sarcoma	2.92e-05	0.000434	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PLCG1—sarcoma	2.92e-05	0.000434	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PDGFRA—sarcoma	2.88e-05	0.000427	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFC—sarcoma	2.87e-05	0.000427	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—HRAS—sarcoma	2.87e-05	0.000426	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—sarcoma	2.81e-05	0.000417	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—MYC—sarcoma	2.78e-05	0.000413	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—ENO2—sarcoma	2.76e-05	0.000411	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—HBA1—sarcoma	2.75e-05	0.000408	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—EGFR—sarcoma	2.72e-05	0.000404	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.71e-05	0.000402	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PLCG1—sarcoma	2.67e-05	0.000397	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—IL2—sarcoma	2.66e-05	0.000395	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PLCG1—sarcoma	2.65e-05	0.000393	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—KRAS—sarcoma	2.53e-05	0.000375	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KDR—sarcoma	2.42e-05	0.00036	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KIT—sarcoma	2.4e-05	0.000357	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.36e-05	0.00035	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.35e-05	0.000349	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PLCG1—sarcoma	2.35e-05	0.000348	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2.34e-05	0.000347	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.32e-05	0.000344	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ENO2—sarcoma	2.31e-05	0.000343	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—FLT1—sarcoma	2.3e-05	0.000341	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—HBA1—sarcoma	2.29e-05	0.000341	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CREB1—sarcoma	2.29e-05	0.00034	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—sarcoma	2.28e-05	0.000339	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PLCG1—sarcoma	2.26e-05	0.000335	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—sarcoma	2.24e-05	0.000333	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KIT—sarcoma	2.23e-05	0.000331	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—NRAS—sarcoma	2.23e-05	0.000331	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—MYC—sarcoma	2.22e-05	0.00033	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CXCR4—sarcoma	2.17e-05	0.000322	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—HRAS—sarcoma	2.15e-05	0.000319	CbGpPWpGaD
Dexamethasone—PGR—Generic Transcription Pathway—MYC—sarcoma	2.15e-05	0.000319	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ATF1—sarcoma	2.14e-05	0.000318	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TLE1—sarcoma	2.13e-05	0.000316	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CREB1—sarcoma	2.12e-05	0.000316	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	2.11e-05	0.000313	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ENO2—sarcoma	2.09e-05	0.00031	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—HBA1—sarcoma	2.07e-05	0.000308	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	2.06e-05	0.000305	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—EGFR—sarcoma	2.03e-05	0.000302	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ENO2—sarcoma	2.01e-05	0.000298	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—HBA1—sarcoma	2e-05	0.000296	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PLCG1—sarcoma	1.96e-05	0.000291	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NPM1—sarcoma	1.92e-05	0.000285	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—KRAS—sarcoma	1.92e-05	0.000285	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.92e-05	0.000285	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MDM2—sarcoma	1.89e-05	0.000281	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.89e-05	0.000281	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.85e-05	0.000275	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ENO2—sarcoma	1.83e-05	0.000271	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—HBA1—sarcoma	1.82e-05	0.00027	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ENO2—sarcoma	1.81e-05	0.000269	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—HBA1—sarcoma	1.8e-05	0.000267	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PLCG1—sarcoma	1.77e-05	0.000263	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MDM2—sarcoma	1.76e-05	0.000261	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.75e-05	0.00026	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PLCG1—sarcoma	1.7e-05	0.000253	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—MYC—sarcoma	1.7e-05	0.000252	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IGF1R—sarcoma	1.68e-05	0.00025	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.67e-05	0.000248	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.67e-05	0.000248	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ENO2—sarcoma	1.66e-05	0.000247	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ENO2—sarcoma	1.66e-05	0.000247	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.66e-05	0.000246	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—HBA1—sarcoma	1.65e-05	0.000245	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CTNNB1—sarcoma	1.63e-05	0.000243	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—HRAS—sarcoma	1.63e-05	0.000242	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—FOXO1—sarcoma	1.6e-05	0.000238	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PDGFRB—sarcoma	1.6e-05	0.000237	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PDGFRA—sarcoma	1.57e-05	0.000234	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL2—sarcoma	1.57e-05	0.000233	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.55e-05	0.000231	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PLCG1—sarcoma	1.55e-05	0.00023	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PLCG1—sarcoma	1.54e-05	0.000228	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCND1—sarcoma	1.53e-05	0.000227	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—JUN—sarcoma	1.53e-05	0.000227	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CTNNB1—sarcoma	1.52e-05	0.000225	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.5e-05	0.000222	CbGpPWpGaD
Dexamethasone—NOS2—Disease—SRC—sarcoma	1.48e-05	0.000219	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.46e-05	0.000216	CbGpPWpGaD
Dexamethasone—NOS2—Disease—NRAS—sarcoma	1.42e-05	0.000211	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PLCG1—sarcoma	1.41e-05	0.00021	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PLCG1—sarcoma	1.41e-05	0.000209	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ENO2—sarcoma	1.39e-05	0.000207	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—HBA1—sarcoma	1.39e-05	0.000206	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—SRC—sarcoma	1.37e-05	0.000204	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CXCR4—sarcoma	1.36e-05	0.000201	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.34e-05	0.000199	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ENO2—sarcoma	1.34e-05	0.000199	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—VEGFA—sarcoma	1.34e-05	0.000198	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—HBA1—sarcoma	1.33e-05	0.000198	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KDR—sarcoma	1.32e-05	0.000197	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MYC—sarcoma	1.32e-05	0.000196	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—NRAS—sarcoma	1.32e-05	0.000196	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ENO2—sarcoma	1.31e-05	0.000195	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.31e-05	0.000195	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ENO2—sarcoma	1.31e-05	0.000194	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—HBA1—sarcoma	1.3e-05	0.000194	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—HBA1—sarcoma	1.3e-05	0.000193	CbGpPWpGaD
Dexamethasone—NOS2—Disease—EGFR—sarcoma	1.29e-05	0.000192	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—MYC—sarcoma	1.24e-05	0.000184	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.24e-05	0.000184	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ENO2—sarcoma	1.24e-05	0.000184	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—HBA1—sarcoma	1.23e-05	0.000183	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MYC—sarcoma	1.23e-05	0.000182	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KRAS—sarcoma	1.22e-05	0.000182	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KIT—sarcoma	1.22e-05	0.000181	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—EGFR—sarcoma	1.2e-05	0.000178	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PLCG1—sarcoma	1.18e-05	0.000176	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CREB1—sarcoma	1.16e-05	0.000173	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PLCG1—sarcoma	1.14e-05	0.000169	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KRAS—sarcoma	1.13e-05	0.000169	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ENO2—sarcoma	1.13e-05	0.000168	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—HBA1—sarcoma	1.13e-05	0.000167	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PLCG1—sarcoma	1.11e-05	0.000165	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PLCG1—sarcoma	1.11e-05	0.000165	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.1e-05	0.000164	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PLCG1—sarcoma	1.05e-05	0.000156	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HRAS—sarcoma	1.04e-05	0.000154	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—MYC—sarcoma	1.03e-05	0.000153	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ENO2—sarcoma	1.01e-05	0.00015	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—sarcoma	1.01e-05	0.00015	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—HBA1—sarcoma	1.01e-05	0.000149	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FOXO1—sarcoma	1e-05	0.000149	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PDGFRB—sarcoma	1e-05	0.000149	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ENO2—sarcoma	9.88e-06	0.000147	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PDGFRA—sarcoma	9.85e-06	0.000146	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—HBA1—sarcoma	9.82e-06	0.000146	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—HRAS—sarcoma	9.65e-06	0.000143	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PLCG1—sarcoma	9.62e-06	0.000143	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MDM2—sarcoma	9.61e-06	0.000143	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ENO2—sarcoma	9.31e-06	0.000138	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—HBA1—sarcoma	9.25e-06	0.000137	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ENO2—sarcoma	9.23e-06	0.000137	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—HBA1—sarcoma	9.17e-06	0.000136	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PLCG1—sarcoma	8.59e-06	0.000128	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL2—sarcoma	8.59e-06	0.000128	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PLCG1—sarcoma	8.38e-06	0.000124	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCND1—sarcoma	8.37e-06	0.000124	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—JUN—sarcoma	8.36e-06	0.000124	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CTNNB1—sarcoma	8.29e-06	0.000123	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PLCG1—sarcoma	7.9e-06	0.000117	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PLCG1—sarcoma	7.83e-06	0.000116	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KIT—sarcoma	7.64e-06	0.000113	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SRC—sarcoma	7.49e-06	0.000111	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—sarcoma	7.3e-06	0.000108	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CREB1—sarcoma	7.27e-06	0.000108	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NRAS—sarcoma	7.21e-06	0.000107	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—sarcoma	6.72e-06	9.97e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—sarcoma	6.57e-06	9.75e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—sarcoma	6.21e-06	9.21e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO2—sarcoma	6.09e-06	9.04e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HBA1—sarcoma	6.05e-06	8.98e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MDM2—sarcoma	6.01e-06	8.93e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—sarcoma	5.97e-06	8.87e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—sarcoma	5.52e-06	8.19e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—sarcoma	5.27e-06	7.83e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CTNNB1—sarcoma	5.19e-06	7.7e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PLCG1—sarcoma	5.17e-06	7.67e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SRC—sarcoma	4.69e-06	6.96e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRAS—sarcoma	4.51e-06	6.7e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—sarcoma	4.2e-06	6.24e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—sarcoma	4.11e-06	6.1e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—sarcoma	3.88e-06	5.76e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—sarcoma	3.3e-06	4.9e-05	CbGpPWpGaD
